Details

Ebola Survivors of Beni

As he does every month, Faustin Kalivanda, a father of four, returns to the Beni General Hospital for a check-up. But this isn’t a routine check-up. Kalivanda has survived Ebola and was under treatment at this very hospital until November. He lost his wife and their five-year-old daughter Ester to the disease. 

He still remembers not only the disease but also the people who helped him recover. 

On 1 November, Kalivanda was discharged after he tested free of the virus. To support survivors like Kalivanda, the DRC Ministry of Health, WHO and partners have put in place a programme that covers three fields: clinical, biological, and psychosocial. The program was established in Beni in November, just as Kalivanda was released. 

WHO’s surveillance team leader, Dr Mory Keita, said, “this program is fully supported by WHO, in implementing the follow-up of people cured of Ebola for a period of one year. I said that the WHO has already funded the renovation of three monitoring sites. A site in Beni, a site in Butembo, and one site in Mangina.”

Each survivor is provided with follow-up visits every month over a period of six months and then every three months for a year.

Dr Kakule Monjobo John, who oversees the follow-up of survivors, said, “today on his second visit, the patient tells me that he is feeling well, there is no threat for his life in the future, that he will evolve very well, and that he is in good health.”

Ebola Survivors of Beni

As of 20 January, 422 people have died in this outbreak, while 245 have survived. Two hundred and seventeen of these survivors are participating in the programme. To support them, 46 staff have been trained on the medical, biological, and psychological follow-up of survivors. 

Since his recovery, Kalivanda has decided to bring his experience to the service of other people infected with the virus. Now he works at the treatment centre himself as a nurse assistant, carrying patients from ambulances to the treatment centre and cleaning patient rooms. He believes that as a survivor he has a mission to help change the perception of Ebola in his community, by showing how survivors can contribute~WHO 

0

Related Article

Posted on: Tuesday, August 13, 2019 | By: crimeandmoreworld - Copy Editing Desk

New Treatment of Ebola

The mortality rate for REGN-EB3 and mAb114 was 29 per cent and 34 per cent respectively, and the drugs worked even better for patients who were treated early -within three days of infection

Posted on: Saturday, July 27, 2019 | By: crimeandmoreworld - Copy Editing Desk

WHO: Low-Cost Generic Drugs Can Eliminate Hepatitis by 2030

The WHO study finds hepatitis could be eliminated as a public health threat in 67 low-and middle-income countries by 2030 for a cost of $6 billion a year or a total of nearly $60 billion. These countries account for 75 percent of the world’s population. The WHO says new hepatitis infections would be reduced by 90 percent and deaths by 65 percent

Posted on: | By: crimeandmoreworld - Copy Editing Desk

Few Countries Implementing Life-Saving Anti-Tobacco Measures

A survey found 36 countries have introduced one or more measures aimed at helping people quit smoking. Only Turkey and Brazil have implemented all of WHO’s recommended anti-tobacco measures.

Posted on: Thursday, July 18, 2019 | By: crimeandmoreworld - Copy Editing Desk

Nearly 50% of Afghans suffer mental illnesses

Half of Afghans have suffered mental illness, according to the ministry of public health

Posted on: Tuesday, July 16, 2019 | By: crimeandmoreworld - News Desk

Global HIV Report by UNAIDS

Globally, around 1.7 million people became newly infected with HIV in 2018, a 16 percent decline since 2010, driven mostly by steady progress across most of Eastern and Southern Africa

Top

Privacy & Cookies: This site uses cookies. By continuing to use this website, you agree to their use.
To find out more, including how to control cookies, see here: Cookie Policy more information

Privacy & Cookies: This site uses cookies. By continuing to use this website, you agree to their use.
To find out more, including how to control cookies, see here: Cookie Policy

Close